Molecular mechanism and targets of the antimicrobial activity of metal nanoparticles

Current Topics in Medicinal Chemistry

Volumn 15, Issue 16, 2015, Pages 1583-1588

  Oktar, Faik N ^a   Yetmez, Mehmet ^b   Ficai, Denisa ^c   Ficai, Anton ^c   Dumitru, Florica ^d   Pica, Alexandra ^c  

^a MARMARA UNIVERSITY   (Turkey)

^b ZONGULDAK KARAELMAS UNIVERSITY   (Turkey)

^c UNIVERSITY POLITEHNICA OF BUCHAREST   (Romania)

^d Research Institute for Advanced Coatings   (Romania)

Author keywords

Antibacterial; Antiviral; Drug multiresistant bacteria; Molecular mechanism

Indexed keywords

METAL NANOPARTICLE; TITANIUM DIOXIDE; ZINC OXIDE; ANTIINFECTIVE AGENT; ANTIVIRUS AGENT; HEAVY METAL; REACTIVE OXYGEN METABOLITE;

ANTIMICROBIAL ACTIVITY; ARTICLE; CELL MEMBRANE; CHEMOTAXIS; DNA REPLICATION; FREE RADICAL SCAVENGING ASSAY; GENE MUTATION; LIPID PEROXIDATION; MOLECULAR BIOLOGY; NONHUMAN; OXIDATIVE STRESS; CHEMISTRY; DRUG EFFECTS; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; METABOLISM; VIRUS GENOME;

ANTI-BACTERIAL AGENTS; ANTIVIRAL AGENTS; GENOME, VIRAL; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; METAL NANOPARTICLES; METALS, HEAVY; REACTIVE OXYGEN SPECIES;

EID: 84930895010     PISSN: 15680266     EISSN: 18734294     Source Type: Journal    
DOI: 10.2174/1568026615666150414141601     Document Type: Article

References (100)

1. Kolar, M.; Urbanek, K.; Latal, T. Antibiotic selective pressure and development of bacterial resistance. Int. J. Antimicrob. Ag., 2001, 17, 357-63.
2. Fischbach, M. A.; Walsh, C. T. Antibiotics for emerging pathogens. Science, 2009, 325 (5944), 1089-1093.
3. Moghimi, S. M. Nanomedicine: prospective diagnostic and therapeutic potential. Asia Pacific Biotech. News, 2005, 9, 1072-77.
4. Hu, W. B.; Peng, C.; Luo, W. J.; Lv, M.; Li, X. M.; Li, D.; Huang, Q.; Fan, C. Graphene-based antibacterial paper. ACS Nano, 2010, 4 (7), 4317-23.
5. D'Costa, V. M.; King, C. E.; Kalan, L.; Morar, M.; Sung, W.; Schwarz, C.; Froese, D.; Zazula, G.; Calmels, F.; Debruyne, R.; Golding, G. B.; Poinar, H. N.; Wright, G. D. Antibiotic resistance is ancient. Nature, 2011, 477, 457-61.
6. Ibrahim, E. H.; Sherman, G.; Ward, S.; Fraser, V. J.; Kollef, M. H. The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. Chest, 2000, 118, 146-55.
7. Feynman, R. There's plenty of room at the bottom. Science, 1991, 254, 1300-01.
8. Yacoby, I.; Benhar, I. Antibacterial nanomedicine. Nanomedicine, 2008, 3 (3), 329-41.
9. Marques, C.; Ferreira, J. M.; Andronescu, E.; Ficai, D.; Sonmez, M.; Ficai, A. Multifunctional materials for bone cancer treatment. Int. J. Nanomedicine, 2014, 9, 2713-25.
10. Pica, A.; Guran, C.; Ficai, D.; Ficai, A.; Oprea, O. Decorative antimicrobial coating materials based on silver nanoparticles. UPB Sci Bull, Series B, 2013, 75, 35-2.
11. Bandyopadhyay, D.; Prashar, D.; Luk, Y. Y. Anti-fouling chemistry of chiral monolayers: enhancing biofilm resistance on racemic surface. Langmuir, 2011, 27 (10), 6124-31.
12. Li, Q.; Mahendra, S.; Lyon, D. Y.; Brunet, L.; Liga, M. V.; Li, D.; Alvarez, P. J. Antimicrobial nanomaterials for water disinfection and microbial control: potential applications and implications. Water Res., 2008, 42 (18), 4591-02.
13. Oprea, O.; Andronescu, E.; Ficai, D.; Ficai, A.; Oktar, F. N.; Yetmez, M. ZnO applications and challenges. Curr. Organic Chem., 2014, 18, 192-03.
14. Guran, C.; Pica, A.; Ficai, D.; Ficai, A.; Comanescu, C., Antimicrobial coatings-obtaining and characterization. Bulletin Mater. Sci., 2013, 36, 183-8.
15. Furno, F.; Morley, K. S.; Wong, B.; Sharp, B. L.; Arnold, P. L.; Howdle, S. M.; Bayston, R.; Brown, P. D.; Winship, P. D.; Reid, H. J. Silver nanoparticles and polymeric medical devices: a new approach to prevention of infection?, J. Antimicrob. Chemother., 2004, 54, 1019-24.
16. Nanda, A.; Saravanan, M. Biosynthesis of silver nanoparticles from Staphylococcus aureus and its antimicrobial activity against MRSA and MRSE. Nanomedicine, 2009, 5, 452-56.
17. Huang, Z.; Zheng, X.; Yan, D.; Yin, G.; Liao, X.; Kang, Y.; Yao, Y.; Huang, D.; Hao, B. Toxicological effect of ZnO nanoparticles based on bacteria. Langmuir, 2008, 24 (8), 4140-44.
18. Jones, N.; Ray, B.; Ranjit, K. T.; Manna, A. C. Antibacterial activity of ZnO nanoparticle suspensions on a broad spectrum of microorganisms. FEMS, Microbiol. Lett., 2008, 279, 71-6.
19. Gou, N.; Onnis Hayden, A.; Gu, A. Z. Mechanistic toxicity assessment of nanomaterials by whole-cell-array stress genes expression analysis. Environ. Sci. Technol., 2010, 44 (15), 5964-70.
20. Su, H.; Chou, C. C.; Hung, D. J.; Lin, S. H.; Pao, I. C.; Lin, J. H.; Huang, F. L.; Dong, R. X.; Lin, J. J. The disruption of bacterial membrane integrity through ROS generation induced by nanohybrids of silver and clay. Biomaterials, 2009, 30, 5979-87.
21. Chaloupka, K.; Malam, Y.; Seifalian, A. M. Nanosilver as a new generation of nanoproduct in biomedical applications. Trends Biotechnol., 2010, 28, 580-88.
22. Choi, O.; Deng, K. K.; Kim, N. J.; Ross, L. Jr.; Surampalli, R. Y.; Hu, Z. The inhibitory effects of silver nanoparticles, silver ions, and silver chloride colloids on microbial growth. Water Research, 2008, 42, 3066-74.
23. Reddy, K. M.; Feris, K.; Bell, J.; Wingett, D. G.; Hanley, C.; Punnoose, A. Selective toxicity of zinc oxide nanoparticles to prokaryotic and eukaryotic systems. Applied Phys. Lett., 2007. 90, 2139021-23.
24. Pica, A.; Ficai, D.; Guran, C. In-situ Synthesis of Nano Silver Particles Used in Obtaining of Antimicrobial Film-Forming Materials. Revista De Chimie, 2012, 63, 459-62.
25. Kim, J. S.; Kuk, E.; Yu, K.; Kim, J. H.; Park, S. J.; Lee, H. J.; Kim, S. H.; Park, Y. K.; Park, Y. H.; Hwang, C. Y.; Kim, Y. K.; Lee, Y. S.; Jeong, D. H.; Cho, M. H. Antimicrobial effects of silver nanoparticles. Nanomedicine, 2007, 3, 95-01.
26. Monopoli, M. P.; Walczyk, D.; Campbell, A.; Elia, G.; Lynch, I.; Baldelli, B. F.; Dawson, K. A. Physical-Chemical Aspects of Protein Corona: Relevance to in vitro and in vivo Biological Impacts of Nanoparticles. J. Am. Chem. Soc., 2011, 133 (8), 2525-34.
27. Walczyk, D.; Bombelli, F. B.; Monopoli, M. P.; Lynch, I.; Dawson, K. A. What the cell "sees" in bionanoscience. J. Am. Chem. Soc., 2010, 132, 5761-68.
28. Lundqvist, M.; Stigler, J.; Elia, G.; Lynch, I.; Cedervall, T.; Dawson, K. A. Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts. Proc. Natl. Acad. Sci. USA, 2008, 105, 14265-70.
29. Pal, S.; Tak, Y. K.; Song, J. M. Does the antibacterial activity of silver nanoparticles depend on the shape of the nanoparticle? A study of the Gram-negative bacterium Escherichia coli. Applied Environ. Microbiol., 2007, 73, 1712-20.
30. Foldbjerg, R.; Dang, D. A.; Autrup, H. Cytotoxicity and genotoxicity of silver nanoparticles in the human lung cancer cell line. A549. Arch. Toxicol., 2011, 85, 743-50.
31. Kawata, K.; Osawa, M.; Okabe, S. In vitro toxicity of silver nanoparticles at noncytotoxic doses to HepG2 human hepatoma cells. Environ. Sci. Technol., 2009, 43, 6046-51.
32. Kim, S.; Choi, J. E.; Choi, J.; Chung, K. H.; Park, K.; Yi, J.; Ryu, D. Y. Oxidative stress-dependent toxicity of silver nanoparticles in human hepatomacells. Toxicol. In vitro, 2000, 9 (23), 1076-84.
33. Krutyakov, A.; Kudrinskiy, A.; Olenin, A. Y.; Lisichkin, G. V. Synthesis and properties of silver nanoparticles: achievements and prospects. Uspehi Himii, 2008. 77, 242-69.
34. Yan, C.; Yuyun, Z.; Yue, T.; Wei, Z.; Xiaoying, L.; Xingyu, J. The molecular mechanism of action of bactericidal gold nanoparticles on Escherichia coli. Biomaterials, 2012, 33, 2327-33.
35. Nedelcu, I. A.; Ficai, A.; Sonmez, M.; Ficai, D.; Oprea, O.; Andronescu, E. Silver based materials for biomedical applications. Curr. Organic Chem., 2014, 18, 173-82.
36. Sondi, I.; Salopek-Sondi, B. Silver nanoparticles as antimicrobial agent: a case study on E. coli as a model for Gram-negative bacteria. J. Colloid Interface Sci., 2004, 275, 177-82.
37. Pica, A.; Guran, C.; Andronescu, E.; Oprea, O.; Ficai, D.; Ficai, A. Antimicrobial performances of some film forming materials based on silver nanoparticles. J. Optoelectronics Adv. Mater., 2012, 14, 863-8.
38. Kim, J. S.; Kuk, E.; Yu, K. N.; Kim, J. H.; Park, S. J.; Lee, H. J.; Kim, S. H.; Park, Y. K.; Hwang, C. Y.; Kim, Y. K.; Lee, Y. S.; Jeong, D. H.; Cho, M. H. Antimicrobial effects of silver nanoparticles. Nanomedicine, 2007, 3, 95-101.
39. Morones, J. R.; Elechiguerra, J. L.; Camacho, A.; Holt, K.; Kouri, J. B.; Ramirez, J. T.; Yacaman, M. J. The bactericidal effect of silver nanoparticles. Nanotechnology, 2005, 16, 2346-53.
40. McQuillan, J. S.; Infante, G.; Stokes, E.; Shaw, A. M. Silver nanoparticle enhanced silver ion stress response in Escherichia coli K12. Nanotoxicology, 2012, 6, 857-66.
41. Dragieva, I.; Stoeva, S.; Stoimenov, P.; Pavlikianov, E.; Klabunde, K. Complex formation in solutions for chemical synthesis of nanoscaled particles prepared by borohydride reduction process. Nanostructured Mater., 2006, 12, 267-70.
42. Călinescu, I.; Pătraşcu, M.; Gavrilă, A. I.; Trifan, A.; Boscornea, C. Synthesis and characterisation of silver nanoparticles in the presence of pva and tannic acid. U. P. B. Sci. Bul., Series B, 2011, 73, 4-12.
43. Chudobova, D.; Maskova, D.; Kopel, P.; Merlos Rodrigo, M. A.; Kizek, R. The effect of silver ions and silver nanoparticles on Staphylococcus aureus. Formatex, 2013, 728-35.
44. Ricco, J. B.; Assadian, O. Antimicrobial Silver Grafts for Prevention and Treatment of Vascular Graft Infection. Semin. Vasc. Surg., 2011, 4, 234-41.
45. Wonyoung, L.; Keuk-Jun, K.; Dong, G. L. A novel mechanism for the antibacterial effect of silver nanoparticles on Escherichia coli. Biometals, 2014, 27 (6), 1191-01.
46. Kim, J. S.; Kuk, E.; Yu, K. N.; Kim, J. H.; Park, S. J.; Lee, H. J.; Kim, S. H.; Park, Y. K.; Park, Y. H.; Hwang, C. Y.; Kim, Y. K.; Lee, Y. S.; Jeong, D. H.; Cho, M. H. Antimicrobial effects of silver nanoparticles. Nanotech. Biol. Med., 2007, 3, 95-01.
47. Zhao, Y.; Tian, Y.; Cui, Y.; Liu, W.; Ma, W.; Jiang, X. Small molecule-capped gold nanoparticles as potent antibacterial agents that target Gram-negative bacteria. J. Amer. Chem. Soc., 2010, 132 (35), 12349-56.
48. Ma, W.; Cui, Y.; Zhao, Y.; Zheng, W.; Zhang, W.; Jiang, X.; Wenjie, Z. Progress of antibacterial mechanisms study on nanoparticles. Acta Biophys Sinica, 2010, 26 (8), 638-48.
49. Boisselier, E.; Astruc, D. Gold nanoparticles in nanomedicine: preparations, imaging, diagnostics, therapies and toxicity. Chem. Soc. Rev., 2009, 38 (6), 1759-82.
50. Giljohann, D. A.; Seferos, D. S.; Daniel, W. L.; Massich, M. D.; Patel, P. C.; Mirkin, C. A. Gold nanoparticles for biology and medicine. Angew Chem. Int. Ed., 2010, 49 (19), 3280-94.
51. Gunther, M. R.; Hanna, P. M.; Mason, R. P.; Cohen, M. S. Hydroxyl radical formation from cuprous ion and hydrogen peroxide: a spin trapping study. Arch. Biochem. Biophys., 1995, 316, 515-22.
52. Tkeshelashvili, L. K.; McBride, T.; Spence, K.; Loeb, L. A. Mutation spectrum of copper-induced DNA damage. J. Biol. Chem., 1991, 266, 6401-06.
53. Macomber, L.; Imlay, J. A. The iron-sulfur clusters of dehydratases are primary intracellular targets of copper toxicity. Proc. Natl. Acad. Sci. USA, 2009, 106, 8344-49.
54. Yoshida, Y.; Furuta, S.; Niki, E. Effects of metal chelating agents on the oxidation of lipids induced by copper and iron, Biochimica et Biophysica Acta (BBA)-Lipids Lipid Metab., 1993, 1210/1, 81-88.
55. Lewis, A.; Keevil, C. W. Antibacterial properties of alloys and its alloys in HVAC&R systems. International CopperAssociation, 2004, New York.
56. Grass, G.; Rensing, C.; Solioz, M. Metallic Copper as an Antimicrobial Surface. Applied Environ. Microbiol., 2011, 77 (5), 1541-47.
57. Jiang, W.; Mashayekhi, H.; Xing, B. Bacterial toxicity comparision between nano-and micro-scale oxide particles. Environmental Pollutio, 2009, 157, 1619-25.
58. Balasubramanyam, A.; Sailaja, N.; Mahboob, M.; Rahman, M. F.; Hussain, S. M.; Grover, P. In vitro mutagenicity assessment of aluminium oxide nanomaterials using the Salmonella/microsome assay. Toxicol. in vitro, 2010, 24, 1871-76.
59. Oberdorster, G.; Stone, V.; Donaldson, K. Toxicology of Nanoparticles: A Historical Perspective. Nanotoxicology, 2007, 1, 2-25.
60. Sawai, J. Quantitative evaluation of antibacterial activities of metallic oxide powders (ZnO, MgO and CaO) by conductimetric assay. J. Microbiol. Methods, 2003, 54, 177-82.
61. Yamamoto, O.; Fukuda, T.; Kimata, M.; Sawai, J.; Sasamoto, T. Antibacterial characteristics of MgO-mounted spherical carbons prepared by carbonization of ion-exchanged resin. J. Ceramic Soc. Jpn., 2000, 109, 363-65.
62. Huang, L.; Li, D.; Lin, Q.; Wei, Y. J.; Evans, M.; Duan, D. G. Controllable preparation of nano-MgO and investigation of its bactericidal properties. J. Inorganic Biochem., 2005, 99, 986-93.
63. 3. J. Mater. Sci.: Mater. Medicine, 2005, 16, 53-6.
64. Yamamoto, O.; Sawai, J.; Sasamoto, T. Change in antibacterial characteristics with doping amount of ZnO in MgO-ZnO solid solution. Int. J. Inorganic Mater., 2000, 2, 451-54.
65. Makhluf, S.; Dror, R.; Nitzan, Y.; Abramovich, Y.; Jelinek, R.; Gedanken, A. Microwave-assisted synthesis of nanocrystalline MgO and its use as a bacteriocide. Adv. Functional Mater., 2005, 15, 1708-15.
66. Hewitt, C. J.; Bellara, S. T.; Andreani, A.; Nebe-von-Caron, G.; Mcfarlane, C. M. An evaluation of the antibacterial action of ceramic powder slurries using multiparameter flow cytometry. Biotech. Lett., 2001, 23, 667-75.
67. Krishnamoorthy, K.; Manivannan, G.; Kim, S. J.; Jeyasubramanian, K.; Premanathan, M. Antibacterial activity of MgO nanoparticles based on lipid peroxidation by oxygen vacancy. J. Nanoparticles Res., 2012, 14, 1063-72.
68. Leung, Y. H.; Xu, X.; Shen, Z.; Gethings, L. A.; Wong, M. T.; Chan, C. M.; Guo, M. Y.; Djurišić, A. B.; Lee, P. K.; Chan, W. K.; Yu, L. H.; Phillips, D. L.; Ma, A. P.; Leung, F. C. Mechanisms of antibacterial activity of MgO: non-ROS mediated toxicity of MgO nanoparticles towards Escherichia coli. Small. 2014, 10, 6, 1171-83.
69. Peter, K. S.; Rosalyn, L.; George, L. M.; Klabunde, J. K. Metal oxide nanoparticles as bactericidal agents. Langmuir, 2002, 3, 6679-86.
70. Makhluf, S.; Dror, R.; Nitzan, Y.; Abramovich, Y.; Jelinek, R.; Gedanken, A. Microwave-assisted synthesis of nanocrystalline MgO and its use as a bacteriocide. Adv. Functional Mater., 2005, 15, 1708-15.
71. Stoimenov, P. K.; Klinger, R. L.; Marchin, G. L.; Klabunde, K. J. Metal oxide nanoparticles as bactericidal agents. Langmuir, 2002, 18, 6679-8.
72. Jiang, W. Bacterial Toxicity of Oxide Nanoparticles and Their Effects on Bacterial Surface Biomolecules, Dissertations and Theses. 2011.
73. Kikuchi, Y.; Sunada, K.; Iyoda, T.; Hashimoto, K.; Fujishima, A. Photocatalytic bactericidal effect of TiO2 thin films: Dynamic view of the active oxygen species responsible for the effect. J. Photochem. Photobiol. Chem., 1997, 106, 51-6.
74. Nadtochenko, V.; Denisov, N.; Sarkisov, O.; Gumy, D.; Pulgarin, C.; Kiwi, J. Laser kinetic spectroscopy of the interfacial charge transfer between membrane cell walls of E. coli and TiO2. J. Photochem. Photobiol. Chem., 2006, 181, 401-07.
75. Nadtochenko, V. A.; Sarkisov, O. M.; Nikandrov, V. V.; Chubukov, P. A.; Denisov, N. N. Inactivation of Pathogenic Microorganisms in the Photocatalytic Process on Nanosized TiO2 Crystals. Russ. J. Phys. Chem. B. Focus Phys., 2008, 2, 105-14.
76. Dalrymple, O. K.; Stefanakos, E.; Trotz, M. A.; Goswami, D. Y. A review of the mechanisms and modeling of photocatalytic disinfection. Applied Catalysis B. Environ., 2010, 98, 27-8.
77. Dalrymple, O. K.; Isaacs, W.; Stefanakos, E.; Trotz, M. A.; Goswami, D. Y. Lipid vesicles as model membranes in photocatalytic disinfection studies. J. Photochem. Photobiol. a-Chem., 2011, 221, 64-70.
78. Gupta, K.; Singh, R. P.; Pandey, A.; Pandey, A. Photocatalytic antibacterial performance of TiO2 and Ag-doped TiO2 against S. aureus. P. aeruginosa and E. coli. J. Nanotechnol., 2013, 4, 345-51.
79. Ruparelia, J. P.; Chatterjee, A. K.; Duttagupta, S. P.; Mukherji, S. Strain specificity in antimicrobial activity of silver and copper nanoparticles. Acta Biomaterialia, 2008, 4, 3, 707-16.
80. 3) to Escherichia coli, Bacillus subtilis, and Streptococcus aureus. Sci. Total Environ., 2011, 409, 1603-08.
81. Juan, L.; Zhimin, Z.; Anchun, M.; Lei, L.; Jingchao, Z. Deposition of silver nanoparticles on titanium surface for antibacterial effect. Int. J. Nanomedicine., 2010, 5, 261-67.
82. Sinha, R.; Karan, R.; Sinha, A.; Khare, S. K. Interaction and nanotoxic effect of ZnO and Ag nanoparticles on mesophilic and halophilic bacterial cells. Bioresour. Technol., 2011, 102, 1516-20.
83. Panacek, A.; Kvitek, L.; Prucek, R.; Kolar, M.; Vecerova, R.; Pizurova, N.; Sharma, V. K.; Nevecna, T.; Zboril, R. Silver colloid nanoparticles: synthesis, characterization, and their antibacterial activity. J. Phys. Chem., 2006, 110, 16248-53.
84. Khan, S. S.; Mukherjee, A.; Chandrasekaran, N. Studies on interaction of colloidal silver nanoparticles (SNPs) with five different bacterial species. Colloids Surf. B: Biointerfaces, 2011, 87, 129-38.
85. Jiang, W.; Mashayekhi, H.; Xing, B. Bacterial toxicity comparison between nano-and micro-scaled oxide particles. Environ. Pollut., 2009, 157, 1619-25.
86. Feris K.; Otto, C.; Tinker, J.; Wingett, D.; Punnoose, A.; Thurber, A.; Kongara, M.; Sabetian, M.; Quinn, B.; Hanna, C.; Pink, D. Electrostatic interactions affect nanoparticlemediated toxicity to gram-negative bacterium Pseudomonas aeruginosa PAO1. Langmuir, 2010, 26, 4429-36.
87. Wu, B.; Huang, R.; Sahu, M.; Feng, X.; Biswas, P.; Tang, Y. J. Bacterial responses to Cu-doped TiO2 nanoparticles. Sci. Total Environ., 2010, 408, 1755-58.
88. Rispoli, F.; Angelov, A.; Badia, D.; Kumar, A.; Seal, S.; Shah, V. Understanding the toxicity of aggregated zero valent copper nanoparticles against Escherichia coli. J. Hazard. Mater., 2010, 180, 212-16.
89. Kumar, A.; Pandey, A. K.; Singh, S. S.; Shanker, R.; Dhawan, A. Cellular uptake and mutagenic potential of metal oxide nanoparticles in bacterial cells. Chemosphere, 2011, 83, 1124-32.
90. Giancivincenzo, P. D.; Marradi, M.; Martinez-Avila, O. M.; Bedoya, L. M.; Alcami, J.; Penades, S. Gold nanoparticles capped with sulfate-ended ligands as anti-HIV agents. Bioorg. Med. Chem. Lett., 2010, 20, 2718-21.
91. Lara, H. H.; Ayala-Nunez, N. V.; Turrent, L. I.; Padilla, C. R. Mode of antiviral action of silver nanoparticles against HIV-1. J. Nanobiotechnol., 2010, 8, 1-9.
92. Pinto, D. B.; Shukla, S.; Perkas, N.; Gedanken, A.; Sarid, R. Inhibition of Herpes Simplex Virus Type 1 Infection by Silver Nanoparticles Capped with Mercaptoethane Sulfonate. Bioconjugate Chem., 2009, 20, 1497-02.
93. Baram-Pinto, D.; Gedanken, A.; Sarid, R. Inhibition of HSV-1 attachment, entry, and cell-to-cell spread by functionalized multivalent gold nanoparticles. Small, 2010, 6 (9), 44-9.
94. Lu, L.; Sun, R. W.; Chen, R.; Hui, C. K.; Ho, C. M.; Luk, J. M.; Lau, G. K.; Che, C. M. Silver nanoparticles inhibit hepatitis B virus replication. Antivir. Ther., 2008, 13, 253-62.
95. Khandelwal, N.; Kaur, G.; Kumar, N.; Tiwari, A. Application of silver nanoparticles in viral inhibition: a new hope for antivirals. Digest J. Nanomater. Biostructures, 2014, 9 (1), 175-86.
96. Sametband, M.; Shukla, S.; Meningher, T.; Hirsh, S.; Mendelson, E.; Sarid, R.; Gedanken, A.; Mandelboim, M. Effective multistrain inhibition of influenza virus by anionic gold nanoparticles. Med. Chem. Commun., 2011, 2, 421-23.
97. Uchide, N.; Ohyama, K.; Bessho, T.; Yuan, B.; Yamakawa, T. Effect of antioxidants on apoptosis induced by influenza virus infection: inhibition of viral gene replication and transcription with pyrrolidine dithiocarbamate. Antiviral Res., 2002, 56, 207-17.
98. Speshock, J. L.; Murdock, R. C.; Braydich-Stolle, L. K.; Schrand, A. M.; Hussain, S. M. Interaction of silver nanoparticles with Tacaribe virus. J. Nanobiotechnol., 2010, 8, 19, 1477-31.
99. Esteban, D. Mechanisms of viral emergence. Vet. Res., 2010, 41, 38-2.
100. He, H.; Dong, X.; Yang, M.; Yang, Q.; Duan, S.; Yu, Y.; Han, J.; Zhang, C.; Chen, L.; Yang, X. Catalytic inactivation of SARS coronavirus, Escherichia coli and yeast on solid surface. Catal. Commun., 2004, 5, 170-72.